These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 18285698)

  • 1. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of high-flux hemodialysis on dialysis-associated amyloidosis.
    Ayli M; Ayli D; Azak A; Yüksel C; Atilgan G; Dede F; Akalin T; Abayli E; Camlibel M
    Ren Fail; 2005; 27(1):31-4. PubMed ID: 15717632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
    Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
    van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
    Krane V; Krieter DH; Olschewski M; März W; Mann JF; Ritz E; Wanner C
    Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between insulin resistance and inflamation markers in hemodialysis patients.
    Borazan A; Binici DN
    Ren Fail; 2010 Jan; 32(2):198-202. PubMed ID: 20199182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of high flux membranes to the therapy of uremia-associated dyslipidemia.
    Azak A; Huddam B; Öneç K; Koçak G; Dede F; Aylı D; Duranay M
    Ther Apher Dial; 2012 Dec; 16(6):595-9. PubMed ID: 23190521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of different dialysis membranes and techniques on the nutritional status, morbidity and mortality of hemodialysis patients].
    Chiappini MG; Ammann T; Selvaggi G; Bravi M; Traietti P
    G Ital Nefrol; 2004; 21 Suppl 30():S190-6. PubMed ID: 15750983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
    Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
    Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.